Picture of Lipocine logo

LPCN — Lipocine News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Lipocine Inc expected to post a loss of 60 cents a share - Earnings Preview

* Lipocine Inc  LPCN.OQ   LPCN.O  is expected to show a rise
in
quarterly revenue when it reports  results 
    * The Salt Lake City Utah-based  company is expected to
report
revenue of $307 thousand, according to the mean estimate from 2
analysts, based on LSEG data.  
    * ​Refinitiv's mean analyst estimate for Lipocine Inc is for
a
loss of 60 cents per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lipocine
Inc is
$38​, above​ its last closing price of $2.58. ​​​

This summary was machine generated November 3 at 18:42 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Lipocine

See all news